Document is current
Any future updates will be listed below
-
Authors
Saals, Bo Anne Daniëlla Frederique
De Bie, Tessa Helena
Osmanoglou, Eral
van de Laar, Ties
Tuin, Adriaan Willem
van Orten-Luiten, Anne Claire Benedikte
Witkamp, Renger Frederik
-
Funding
Funding for this research was provided by:
Wageningen University
Becanex GmbH
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 21 January 2025
First Online: 29 January 2025
Declarations
:
: The author BS and co-authors AvO, and RW declare no competing interests. TvdL was an employee of Becanex GmbH at the time of the trial; EO is an employee of the company. Becanex GmbH did not influence the design or execution of the study. AWT is an employee of Ardena, the company responsible for the sample analysis. The final approval of the manuscript was solely the responsibility of RW as the overall project leader and PI.
: All study procedures were conducted according to the principles of the Declaration of Helsinki (64th WMA General Assembly, Fortaleza, Brazil, October 2013) and with the Medical Research Involving Human Subjects Act (WMO). All study participants gave their written informed consent. The protocol (NL74963.041.21) was approved on December 24, 2021, by the METC (Medical Ethics Committee) of Utrecht University. There was no competent authority approval needed for this study, as the METC decided to assess the trial as nutritional research.
